Sources | Names Used |
---|---|
CTRPv2 | selumetinib:vorinostat (8:1 mol/mol) |
PharmacoGx | selumetinib:vorinostat (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DPF1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | DAPK3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | TCF19 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | SYTL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | TXNRD1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | DEDD2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
mRNA | WIPF1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | BRE | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | GPA33 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | SERAC1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |